Latest Breaking News On - Can fite biopharma - Page 2 : comparemela.com

Can Fite BioPharma : NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K

NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON June 26, 2024 To the shareholders of Can-Fite BioPharma Ltd.: .

Can Fite BioPharma : Immediate Report of Meeting

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of.

Can-Fite BioPharma (NYSE:CANF) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a report released on Thursday morning. The firm issued a hold rating on the stock. Separately, HC Wainwright reiterated a buy rating and set a $18.00 price target on shares of Can-Fite BioPharma in a research report on Thursday, May 9th. Get […]

Can-Fite: 75 Oncologists and Coordinators from Europe US and Israel Participated in a Conference Aimed at Accelerating Patient Enrolment for the Pivotal Phase 3 Advanced Liver Cancer Study

Can Fite BioPharma : Immediate Report - MarketScreener